Cargando…
DDRE-07. FATTY ACID SYNTHESIS IS REQUIRED FOR BREAST CANCER BRAIN METASTASIS
Brain metastases are refractory to therapies that otherwise control systemic disease in patients with human epidermal growth factor receptor 2 (HER2+) breast cancer, and the unique brain microenvironment contributes to this therapy resistance. Nutrient availability can vary across tissues, therefore...
Autores principales: | Ferraro, Gino, Ali, Ahmed, Luengo, Alba, Kodack, David, Deik, Amy, Abbott, Keene, Bezwada, Divya, Blanc, Landry, Prideaux, Brendan, Jin, Xin, Possada, Jessica, Chen, Jiang, Chin, Christopher, Amoozgar, Zohreh, Ferreira, Raphael, Chen, Ivy, Naxerova, Kamila, Ng, Christopher, Westermark, Anna, Duquette, Mark, Roberge, Sylvie, Lyssiotis, Costas, Duda, Dan, Golub, Todd, Cantley, Lewis, Asara, John, Davidson, Shawn, Fukumura, Dai, Dartois, Véronique, Clish, Clary, Heiden, Matthew Vander, Jain, Rakesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7992317/ http://dx.doi.org/10.1093/noajnl/vdab024.029 |
Ejemplares similares
-
DDRE-22. TARGETING SERINE SYNTHESIS IN BRAIN METASTASIS
por: Ngo, Bryan, et al.
Publicado: (2021) -
DDRE-30. THERAPEUTIC TARGETING OF DISRUPTED METABOLIC STATE IN DIFFUSE INTRINSIC PONTINE GLIOMA
por: Mbah, Nneka, et al.
Publicado: (2021) -
DDRE-24. TARGETING PURINE METABOLISM TO OVERCOME GLIOBLASTOMA THERAPY RESISTANCE
por: Zhou, Weihua, et al.
Publicado: (2021) -
Anti-VEGF therapy improves EGFR-vIII-CAR-T cell delivery and efficacy in syngeneic glioblastoma models in mice
por: Dong, Xinyue, et al.
Publicado: (2023) -
DDRE-34. TARGETING RESISTANCE IN MEDULLOBLASTOMA
por: Chang, Simone, et al.
Publicado: (2021)